Proactive Investors

Proactiveinvestors is a prominent multimedia news company, an investor platform, and an events management firm, with locations in New York, Sydney, Toronto, Frankfurt, and London. This organization runs five financial websites in four different languages, delivering up-to-the-minute news, insights, and analysis on numerous publicly traded companies worldwide every day. We are among the fastest-growing financial media platforms globally. Additionally, Proactiveinvestors hosts highly successful "investor forums," where three to four companies showcase their offerings to a select audience of affluent investors, fund managers, hedge funds, private client brokers, and analysts.

International, Trade/B2B

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#340795

United States

#220315

Finance/Investing

#2149

Traffic sources

Monthly visitors

Articles

Lancaster targets maiden drill at Cargelligo in 2025 - ICYMI

6 days ago | proactiveinvestors.com | Angela Harmantas

Mining This record is published on behalf of Lancaster Resources Inc, a paid client of ProactiveAbout this content Disclaimer No investment advice About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks.
Alvopetro sees strong start, eyes 25% output boost - ICYMI

1 week ago | proactiveinvestors.com | Angela Harmantas

EnergyOil & Gas This record is published on behalf of Alvopetro Energy Ltd, a paid client of ProactiveAbout this content Disclaimer No investment advice About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks.
Frank Talk: Trump tariffs trigger collapse in China-to-US shipping volumes

1 week ago | proactiveinvestors.com | Angela Harmantas

The shelves at major U.S. retailers may look full for now, but a dramatic slowdown in trade between the U.S. and China is quietly building into what could become a full-blown supply shock. In this guest article, Frank Holmes, CEO of U.S. Global Investors (NASDAQ:GROW), breaks down how President Trump’s sweeping new tariffs—some as high as 145%—are already reshaping shipping patterns, threatening retail inventory, and prompting layoffs in freight and logistics.
Tiziana Life Sciences reports reduced brain inflammation in Alzheimer’s patient treated with nasal foralumab

1 week ago | proactiveinvestors.com | Angela Harmantas

Tiziana Life Sciences Ltd (NASDAQ:TLSA) said on Friday that a patient with moderate Alzheimer’s disease showed a marked reduction in brain inflammation after three months of treatment with its lead drug candidate, intranasal foralumab, under an expanded access program. A PET scan revealed a significant decrease in microglial activation—an indicator of neuroinflammation linked to Alzheimer’s progression—according to data presented by Dr Howard Weiner at the 2025 AD/PD Conference in Vienna.
Lisata eyes key trial milestones in 2025 as certepetide development gains momentum

1 week ago | proactiveinvestors.com | Angela Harmantas

Lisata Therapeutics Inc (NASDAQ:LSTA) said on Thursday it expects a data-rich year ahead as it advances multiple trials of its lead asset, certepetide, a novel peptide-based therapy being tested in a range of solid tumors.
Alvopetro Q1 sales jump as Canadian wells beat expectations

1 week ago | proactiveinvestors.com | Angela Harmantas

Alvopetro Energy Ltd (TSX-V:ALV, OTC:ALVOF) reported a 41% surge in first-quarter 2025 sales volumes and said its new Canadian oil wells are outperforming expectations, helping to support an organically funded capital program across Brazil and Canada.
Synchronoss delivers steady Q1 as recurring revenue climbs, debt restructured

1 week ago | proactiveinvestors.com | Angela Harmantas

Synchronoss Technologies Inc (NASDAQ:SNCR) delivered a solid first quarter, driven by cloud subscriber growth, high recurring revenue, improved margins, and strong operational execution The personal cloud software provider reported first-quarter results in line with its expectations on Tuesday and said it had completed a $200 million refinancing that strengthens its balance sheet.
Tiziana shares surge on encouraging results for nasal MS drug in early study

1 week ago | proactiveinvestors.com | Ian Lyall |Angela Harmantas

HealthPharma & Biotech This record is published on behalf of Tiziana Life Sciences Ltd, a paid client of ProactiveAbout this content Disclaimer No investment advice About Ian Lyall Ian Lyall, a seasoned journalist and editor, brings over three decades of experience to his role as Managing Editor at Proactive.
Tiziana reports encouraging results for nasal MS drug in early study

1 week ago | proactiveinvestors.com | Ian Lyall

HealthPharma & Biotech This record is published on behalf of Tiziana Life Sciences Ltd, a paid client of ProactiveAbout this content Disclaimer No investment advice About Ian Lyall Ian Lyall, a seasoned journalist and editor, brings over three decades of experience to his role as Managing Editor at Proactive.
Ocean Power Technologies wins contract to deliver unmanned vehicles to Allied Forces

1 week ago | proactiveinvestors.com | Angela Harmantas

Tech This record is published on behalf of Ocean Power Technologies Inc, a paid client of ProactiveAbout this content Disclaimer No investment advice About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks.